Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Mar 2022 for Alzamend Neuro, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Andrew H. Woo: trading record in brief
Andrew H. Woo (board member) discloses dealings in Alzamend Neuro, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 13 September 2021 and the latest from 15 March 2022.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 16 March 2022, the filings show an option exercise in Alzamend Neuro, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew H. Woo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
50,000 shares0Common StockSEC:0001214659-22-004019:0
47,222 shares0Common StockSEC:0001214659-21-010558:0
2,778 shares0Common StockSEC:0001214659-21-009541:0
3 of 3 declarations
